These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4414936)

  • 1. Oral contraceptive compounds and mammalian oocyte meiosis.
    Jagiello G; Lin JS
    Am J Obstet Gynecol; 1974 Oct; 120(3):390-406. PubMed ID: 4414936
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oral contraceptive steroids on plasma renin activity (PRA) in rhesus monkeys.
    Milanian I; Siddiqui HH; Bajaj JS
    Indian J Med Res; 1986 Dec; 84():640-4. PubMed ID: 2437027
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of the serum level of pregnancy-associated alpha2-globulin during contraceptive treatment by means of radial immunodiffusion method.
    Than GN; Csaba IF; Karg NJ; Szabo DG
    Int J Fertil; 1975; 20(1):27-9. PubMed ID: 57103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of norethynodrel with mestranol on menstrual fluid volume.
    Schmidt RM
    Fertil Steril; 1966; 17(3):381-5. PubMed ID: 4952096
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral: effects of oral contraceptives, pregnancy, and lactation.
    Goldsmith NF; Johnston JO
    J Bone Joint Surg Am; 1975 Jul; 57(5):657-68. PubMed ID: 1150709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic influence of oral contraceptives.
    Anberg A
    Acta Obstet Gynecol Scand; 1966; 45(S9):40. PubMed ID: 5958395
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):558-62. PubMed ID: 5779248
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of the ethynyl estrogens used in oral contraceptives. I. Endometrial response.
    Goldzieher JW; Maqueo M; Chenault CB; Woutersz TB
    Am J Obstet Gynecol; 1975 Jul; 122(5):615-8. PubMed ID: 1146926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications of striatal dopamine levels by steroid contraceptive drugs in mice and rats.
    Jori A; Dolfini E
    Neuroendocrinology; 1976; 21(1):74-8. PubMed ID: 1004687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral contraceptive steroids on jejunal pyruvate kinase and adenyl cyclase activities.
    Stifel FB; Greene HL; Herman RH
    Endocrinology; 1971 Sep; 89(3):896-7. PubMed ID: 4105307
    [No Abstract]   [Full Text] [Related]  

  • 15. Some effects of oral contraceptives on serum-lipid and lipoprotein levels.
    Wynn JW; Doar JW; Mills GL
    Lancet; 1966 Oct; 2(7466):720-3. PubMed ID: 4162056
    [No Abstract]   [Full Text] [Related]  

  • 16. An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
    Moore DE; Kawagoe S; Davajan V; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1978 Feb; 130(4):482-6. PubMed ID: 204191
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral administration of a norethynodrel-mestranol combination (Enovid) in rats.
    Husain SM; Pincus G
    Rev Can Biol; 1968 Sep; 27(3):217-24. PubMed ID: 5702438
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of hepatic delta-amino-levulinic acid synthetase by oral contraceptive steroids.
    Rifkind AB; Gillette PN; Song CS; Kappas A
    J Clin Endocrinol Metab; 1970 Mar; 30(3):330-5. PubMed ID: 4189570
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the site of action of oral contraceptive steroids. I. Effect of antifertility steroids on plasma LH levels and on the response to luteinizing hormone-releasing factor in rats.
    Schally AV; Carter WH; Saito M; Arimura A; Bowers CY
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1747-55. PubMed ID: 4177382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.